Ibex Investors LLC Theravance Biopharma, Inc. Transaction History

Ibex Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$16.51 - $23.78 $746,664 - $1.08 Million	-45,225 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$15.6 - $25.15 $204,391 - $329,515	13,102 Added 40.79%	45,225 $739,000
Q1 2019 May 07, 2019	SELL	$22.57 - $28.15 $83,080 - $103,620	-3,681 Reduced 10.28%	32,123 $728,000
Q4 2018 Feb 13, 2019	SELL	$22.52 - $35.07 $231,888 - $361,115	-10,297 Reduced 22.34%	35,804 $916,000
Q3 2018 Nov 13, 2018	BUY	$22.83 - $32.67 $1.05 Million - $1.51 Million	46,101 New	46,101 $1.51 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $636M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Ibex Investors LLC with notifications on news.